Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis Article

Eedara, Basanth Babu, Tucker, Ian G, Das, Shyamal C. (2016). Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis . International Journal of Pharmaceutics, 506(1-2), 174-183. 10.1016/j.ijpharm.2016.04.038

cited authors

  • Eedara, Basanth Babu; Tucker, Ian G; Das, Shyamal C

sustainable development goals

authors

publication date

  • June 15, 2016

published in

keywords

  • 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine (DPPC)
  • AEROSOL DISPERSION PERFORMANCE
  • Aerosolization
  • DELIVERY
  • DRY POWDER
  • Dry powder inhalation
  • FORMULATIONS
  • INHALATION
  • Life Sciences & Biomedicine
  • MYCOBACTERIUM-TUBERCULOSIS
  • NANOPARTICLES
  • OPTIMIZATION
  • PARTICLES
  • PHYSICAL-CHARACTERISTICS
  • Pharmacology & Pharmacy
  • Pyrazinamide
  • Science & Technology
  • Spray drying
  • Tuberculosis

Digital Object Identifier (DOI)

start page

  • 174

end page

  • 183

volume

  • 506

issue

  • 1-2